2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 | 新 已发表SCI？是时候来Springer出书了！ |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Letters in Drug Design & Discovery LETT DRUG DES DISCOV （此期刊被最新的JCR期刊SCIE收录） LetPub评分 5.1
52人评分
我要评分
声誉 6.4 影响力 3.8 速度 6.9 | |||||||||||||||||||||||||
| 期刊ISSN | 1570-1808 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||||||
| E-ISSN | 1875-628X | |||||||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：1.53 | |||||||||||||||||||||||||
| 2025-2026自引率 | 6.2%点击查看自引率趋势图 | |||||||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 1.396数据由网友[期待秘密]收集提供 | |||||||||||||||||||||||||
| h-index | 28 | |||||||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||
| 期刊官方网站 | http://benthamscience.com/journal/index.php?journalID=lddd | |||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||
| 期刊投稿网址 | http://benthamscience.com/journals/letters-in-drug-design-and-discovery/submit-abstracts-online/#top | |||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | GelMA@DFO hydrogel promotes bone regeneration via HIF-1α- mediated angiogenesis Author: Zheng, Xiao; Han, Hongjie; Mao, Binjie; Xie, Jin Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2026; Vol. 23, Issue 2, pp. -. DOI: 10.1016/j.lddd.2026.100391 Camptothecin inhibits HCC progression via modulating MMP9 expression Author: Li, Haide; Wang, Yunfei; Tan, Meie; Su, Wenling; Zhumabieke, Shuhela; Haimiti, Payiman; Yu, Ning; Zheng, Ruifang Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2026; Vol. 23, Issue 2, pp. -. DOI: 10.1016/j.lddd.2026.100377 Multitarget mechanism of berberine against cervical cancer: An integrated study of network pharmacology and molecular docking Author: Tan, Yue; Luo, Weiming; Li, Yunhai Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2026; Vol. 23, Issue 2, pp. -. DOI: 10.1016/j.lddd.2026.100332 Matrine protects human glomerular mesangial cells from lipopolysaccharide-induced Injury via the MCP-1/CCR2 axis and TLR4/NF-κB pathway in glomerulonephritis Author: Wei, Huanbing; Dai, Yunfeng; Gao, Ying; Jia, Weiwei; Li, Ang Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2026; Vol. 23, Issue 1, pp. -. DOI: 10.1016/j.lddd.2026.100346 | |||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Letters in Drug Design & Discovery的语言要求，还能让Letters in Drug Design & Discovery编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Letters in Drug Design & Discovery编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||||||
| 通讯方式 | BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR | |||||||||||||||||||||||||
| 出版商 | Bentham Science Publishers B.V. | |||||||||||||||||||||||||
| 涉及的研究方向 | 医学-医药化学 | |||||||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||
| 出版周期 | Bimonthly | |||||||||||||||||||||||||
| 出版年份 | 2004 | |||||||||||||||||||||||||
| 年文章数 | 227点击查看年文章数趋势图 | |||||||||||||||||||||||||
| Gold OA文章占比 | 30.21% | |||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 96.92% | |||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||
  | ||||||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1570-1808%5BISSN%5D | |||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 平均3.0个月 | |||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 容易 | |||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Letters in Drug Design & Discovery顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | GelMA@DFO hydrogel promotes bone regeneration via HIF-1α- mediated angiogenesis Author: Zheng, Xiao; Han, Hongjie; Mao, Binjie; Xie, Jin Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2026; Vol. 23, Issue 2, pp. -. DOI: 10.1016/j.lddd.2026.100391 DOI |
| 2. | Camptothecin inhibits HCC progression via modulating MMP9 expression Author: Li, Haide; Wang, Yunfei; Tan, Meie; Su, Wenling; Zhumabieke, Shuhela; Haimiti, Payiman; Yu, Ning; Zheng, Ruifang Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2026; Vol. 23, Issue 2, pp. -. DOI: 10.1016/j.lddd.2026.100377 DOI |
| 3. | Multitarget mechanism of berberine against cervical cancer: An integrated study of network pharmacology and molecular docking Author: Tan, Yue; Luo, Weiming; Li, Yunhai Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2026; Vol. 23, Issue 2, pp. -. DOI: 10.1016/j.lddd.2026.100332 DOI |
| 4. | Matrine protects human glomerular mesangial cells from lipopolysaccharide-induced Injury via the MCP-1/CCR2 axis and TLR4/NF-κB pathway in glomerulonephritis Author: Wei, Huanbing; Dai, Yunfeng; Gao, Ying; Jia, Weiwei; Li, Ang Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2026; Vol. 23, Issue 1, pp. -. DOI: 10.1016/j.lddd.2026.100346 DOI |
| 5. | Unveiling biomarkers of chemoresistance: CASP1, ENG, and H6PD in 5-Fu-treated colorectal cancer Author: Huang, Xiang; Hua, Long; Ye, Junhao; Zhu, Lijun; Zhu, Yiping Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2026; Vol. 23, Issue 1, pp. -. DOI: 10.1016/j.lddd.2026.100375 DOI |
| 6. | Research progress on the mechanism and intervention strategies of MET protein in regulating the resistance to targeted therapy for EGFR-mutated non-small cell lung cancer Author: Chen, Fanghong; Zhang, Hangyue; Wang, Chengcheng; Liu, Menglan; Gao, Xudong; Wang, Jianxia; Shen, Li Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2026; Vol. 23, Issue 1, pp. -. DOI: 10.1016/j.lddd.2026.100357 DOI |
| 7. | Epigallocatechin gallate impels osteogenic differentiation of human BMSCs by targeting the METTL3/SATB2/Wnt/β-catenin axis Author: Ren, Qiao; Chen, Kang; Wang, Lin Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2025; Vol. 22, Issue 3, pp. -. DOI: 10.1016/j.lddd.2025.100027 DOI |
| 8. | Efficacy analysis of Salmeterol Xinafoate and Fluticasone Propionate power for inhalation in treating pediatric asthma patients Author: Zheng, Bojuan; Gao, Lianlian; Zhou, Liang; Li, Jinying; Tian, Liyuan; Yuan, Jie Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2025; Vol. 22, Issue 2, pp. -. DOI: 10.1016/j.lddd.2025.100020 DOI |
| 9. | Puerarin alleviates spinal cord injury by mediating the proliferation and activation of NG2 glial cells Author: Ye, Ping; Liao, Xinyuan; Zhao, Yin; Zhou, Shengyuan; Guo, Xiang; Yang, Lili; Lv, Bitao Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2025; Vol. 22, Issue 2, pp. -. DOI: 10.1016/j.lddd.2025.100011 DOI |
| 10. | The mechanism of Peilian Ephehuang Prescription in the treatment of simple obesity based on network pharmacology and molecular docking technology Author: Wen, Nuan; Gu, Changrui; Zhao, Ying; Ma, Jian Journal: LETTERS IN DRUG DESIGN & DISCOVERY. 2025; Vol. 22, Issue 2, pp. -. DOI: 10.1016/j.lddd.2025.100019 DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共4条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
